Synthetic mRNA Production Landscape Assessment
Pharma & Biotech
12
84
21
Voice-of-Customer Research
Competitive Analysis
Market Landscaping and Sizing
Objective
A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy
Our Approach
Secondary Research
- Aggregated secondary research of the therapeutic mRNA space and market demand for manufacturing
- Summarized key specifications required and demand drivers for external manufacturing
- Assessed the CMO competitive landscape
Primary Research
- Conducted 12 in-depth stakeholder interviews with biopharma stakeholders with direct experience synthesizing and using mRNA for therapeutic applications
- Interviewees included experts across public and private biopharma who utilize mRNA for a diverse range of therapeutic applications
Quantitative Analysis
- Built a bottoms-up model estimating the demand and production level of synthetic mRNA today and in five years within biopharma by application area and phase of development
Outcome
DeciBio shared research findings with the client, key takeaways included:
- Estimated opportunity for external mRNA manufacturing in 2019 and 2024.
- Outlined customer requirements and key considerations and recommendations to help inform the client’s acquisition strategy
Related Client Results
Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing
Customer Segmentation
Voice-of-Customer Research
Market Landscaping and Sizing
Low-Throughput Molecular Diagnostic Testing Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Infectious Pathogen Diagnostics Technology Commercialization
Voice-of-Customer Research
